Ownership history in VAN ECK ASSOCIATES CORP · 18 quarters on record
This page tracks every 13F SEC filing in which VAN ECK ASSOCIATES CORP reported a position in Blueprint Medicines Corp (BPMC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 132 | -872 | -86.9% | 0.00% | $17K | — |
| 2025 Q2 | REDUCED | 1,004 | -112 | -10.0% | 0.00% | $129K | — |
| 2025 Q1 | UNCHANGED | 1,116 | — | 0% | 0.00% | $99K | — |
| 2024 Q4 | ADDED | 1,116 | +363 | +48.2% | 0.00% | $97K | — |
| 2024 Q3 | REDUCED | 753 | -363 | -32.5% | 0.00% | $64K | — |
| 2024 Q2 | ADDED | 1,116 | +131 | +13.3% | 0.00% | $120K | — |
| 2024 Q1 | ADDED | 985 | +113 | +13.0% | 0.00% | $93K | — |
| 2023 Q4 | ADDED | 872 | +193 | +28.4% | 0.00% | $80K | — |
| 2023 Q3 | UNCHANGED | 679 | — | 0% | 0.00% | $34K | — |
| 2023 Q2 | REDUCED | 679 | -146 | -17.7% | 0.00% | $43K | — |
As of 2025 Q3 — sorted by position size